These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29159213)

  • 1. Dataset generated for Dissection of mechanisms of Trypanothione Reductase and Tryparedoxin Peroxidase through dynamic network analysis and simulations in leishmaniasis.
    Kumar A; Saha B; Singh S
    Data Brief; 2017 Dec; 15():757-769. PubMed ID: 29159213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
    Nateghi-Rostami M; Tasbihi M; Darzi F
    Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
    Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
    Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
    Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
    Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Cross-Talk of Redox Metabolism and Fe-S Cluster Biogenesis in Leishmania Through Systems Biology Approach.
    Kumar A; Chauhan N; Singh S
    Front Cell Infect Microbiol; 2019; 9():15. PubMed ID: 30778378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target.
    González-Chávez Z; Olin-Sandoval V; Rodíguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    Biochim Biophys Acta; 2015 Feb; 1850(2):263-73. PubMed ID: 25450181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review.
    Ilari A; Fiorillo A; Baiocco P; Poser E; Angiulli G; Colotti G
    Mini Rev Med Chem; 2015; 15(3):243-52. PubMed ID: 25769972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structures of the tryparedoxin-tryparedoxin peroxidase couple unveil the structural determinants of Leishmania detoxification pathway.
    Fiorillo A; Colotti G; Boffi A; Baiocco P; Ilari A
    PLoS Negl Trop Dis; 2012; 6(8):e1781. PubMed ID: 22928053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox metabolism in Trypanosoma cruzi: functional characterization of tryparedoxins revisited.
    Arias DG; Marquez VE; Chiribao ML; Gadelha FR; Robello C; Iglesias AA; Guerrero SA
    Free Radic Biol Med; 2013 Oct; 63():65-77. PubMed ID: 23665397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
    Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
    Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
    Venkatesan SK; Shukla AK; Dubey VK
    J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania infantum: provision of reducing equivalents to the mitochondrial tryparedoxin/tryparedoxin peroxidase system.
    Castro H; Romao S; Gadelha FR; Tomás AM
    Exp Parasitol; 2008 Dec; 120(4):421-3. PubMed ID: 18809403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of mitochondrial and cytosolic trypanothione-dependent tryparedoxin peroxidases in Trypanosoma brucei.
    Tetaud E; Giroud C; Prescott AR; Parkin DW; Baltz D; Biteau N; Baltz T; Fairlamb AH
    Mol Biochem Parasitol; 2001 Sep; 116(2):171-83. PubMed ID: 11522350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase.
    Suman SS; Equbal A; Zaidi A; Ansari MY; Singh KP; Singh K; Purkait B; Sahoo GC; Bimal S; Das P; Ali V
    Biochimie; 2016 Feb; 121():312-25. PubMed ID: 26743980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis.
    Dukhyil AAAB
    Infect Disord Drug Targets; 2019; 19(4):388-393. PubMed ID: 29732996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryparedoxin peroxidase of Leishmania braziliensis: homology modeling and inhibitory effects of flavonoids for anti-leishmanial activity.
    Gundampati RK; Sahu S; Shukla A; Pandey RK; Patel M; Banik RM; Jagannadham MV
    Bioinformation; 2014; 10(6):353-7. PubMed ID: 25097378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Exploration of the Trypanothione Reductase (TryR) of
    Barrera-Téllez FJ; Prieto-Martínez FD; Hernández-Campos A; Martínez-Mayorga K; Castillo-Bocanegra R
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine-trypanothione pathway: an update.
    Ilari A; Fiorillo A; Genovese I; Colotti G
    Future Med Chem; 2017 Jan; 9(1):61-77. PubMed ID: 27957878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites.
    Sarfraz M; Bakht MA; Alshammari MS; Alrofaidi M; Alzahrani AR; Eltaib L; Asdaq SMB; Aba Alkhayl FF; Abida ; Mohd Imran
    J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38213287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.